Concepedia

Mark R. Szewczak

MR

11

Publications

778

Citations

10

H-Index

1978

Active since

Affiliations

Vion Pharmaceuticals (United States)(Current)

Somerville Hospital

CNS Research (United States)

Mark R. Szewczak is an author at Vion Pharmaceuticals (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1978–1997

11

Publications

11

A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions.

Sharmonay Fielding, Jeffrey C. Wilker, Mary Hynes et al. · Journal of Pharmacology and Experimental Therapeutics · 1978 · 225 citations

Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder

A. T. WOODS, Craig P. Smith, Mark R. Szewczak et al. · Psychopharmacology · 1993 · 132 citations

, , +12

9-Amino-1,2,3,4-tetrahydroacridin-1-ols. Synthesis and evaluation as potential Alzheimer's disease therapeutics

G. M. SHUTSKE, Frank A. Pierrat, Kevin J. Kapples et al. · Journal of Medicinal Chemistry · 1989 · 103 citations · Full text

, , +17

3-[[(Aryloxy)alkyl]piperidinyl]-1,2-Benzisoxazoles as D2/5-HT2 Antagonists with Potential Atypical Antipsychotic Activity: Antipsychotic Profile of Iloperidone (HP 873)

Joseph T. Strupczewski, Kenneth J. Bordeau, Yulin Chiang et al. · Journal of Medicinal Chemistry · 1995 · 86 citations · Full text

The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.

Mark R. Szewczak, Roy Corbett, Douglas K. Rush et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 60 citations

Rows per page

1–5 of 11